Medthority

Medthority Get closer to the conversations that matter in medicine, with our award-winning medical education platform.

From podcast episodes to videos and articles, our channel showcases the latest resources on medthority.com

Attending  ? Stay up to date on the latest advances in hemophagocytic lymphohistiocytosis / macrophage activation syndro...
11/06/2026

Attending ? Stay up to date on the latest advances in hemophagocytic lymphohistiocytosis / macrophage activation syndrome (HLH/MAS) with the HLH/MAS Learning Zone on Medthority, including an on-demand masterclass with Fabrizio de Benedetti and expert podcast series hosted by Michael Jordan

https://ow.ly/bF1Q50Z9MYw

Prep for   by browsing the   hub on Medthority for on-demand resources, including our AL amyloidosis podcast hosted by S...
10/06/2026

Prep for by browsing the hub on Medthority for on-demand resources, including our AL amyloidosis podcast hosted by Shaji Kumar, covering everything from disease impact to multidisciplinary care

https://ow.ly/ZRkA50Z9Myj

Read   insights from Neeraj Agarwal and Mary‑Ellen Taplin on rPFS benefit in mCSPC and improved MFS in high-risk disease...
08/06/2026

Read insights from Neeraj Agarwal and Mary‑Ellen Taplin on rPFS benefit in mCSPC and improved MFS in high-risk disease, highlighting advances across the disease continuum

https://ow.ly/zuJF50Z8SN2

Watch Bjørn Henning Grønberg discuss the latest insights in extensive‑stage small cell lung cancer from  , including why...
05/06/2026

Watch Bjørn Henning Grønberg discuss the latest insights in extensive‑stage small cell lung cancer from , including why adding thoracic radiotherapy may not improve survival, and what this means for practice

Now available on the Medthority YouTube channel

https://ow.ly/Mnxu50Z7A7g

What’s shaping treatment decisions in lung cancer? Read our short summary articles on key data from  , including insight...
04/06/2026

What’s shaping treatment decisions in lung cancer? Read our short summary articles on key data from , including insights on second-line SCLC strategies and first-line NSCLC approaches from Shun Lu and Tony Mok

https://ow.ly/V4rQ50Z7uFV

What really matters to patients with bladder cancer? Read key insights from Maria De Santis and Peter O’Donnell at   on ...
03/06/2026

What really matters to patients with bladder cancer? Read key insights from Maria De Santis and Peter O’Donnell at on preserving quality of life across NMIBC and MIBC, covering the latest data and what this means for practice

https://ow.ly/PZmi50Z7bag

  starts today! Follow us over on X and Bluesky for live coverage and the latest updates in prostate, lung, and bladder ...
29/05/2026

starts today! Follow us over on X and Bluesky for live coverage and the latest updates in prostate, lung, and bladder cancer. Also, don't forget to catch up on the data you need to know about with our summary articles, coming soon on Medthority 👀

X: https://ow.ly/faFL50Z53Co
Bluesky: https://ow.ly/qslg50Z53Cp

As   draws to a close, take a look at our   hub for expert-led, on-demand resources, including ACR 2025 highlights and a...
28/05/2026

As draws to a close, take a look at our hub for expert-led, on-demand resources, including ACR 2025 highlights and an HLH/MAS masterclass with Fabrizio de Benedetti

https://ow.ly/fkqx50Z52Mp

Register now to access the EBAC-accredited recording of Medthority’s on-demand symposium at  , and hear Caterina Garone,...
22/05/2026

Register now to access the EBAC-accredited recording of Medthority’s on-demand symposium at , and hear Caterina Garone, Yolanda Cámara, and Cristina Domínguez González explore effective treatment disease mechanisms in thymidine kinase 2 deficiency (TK2d), emerging clinical evidence, and real-world practice

https://ow.ly/Zl6Q50Z1JPu

Address

6 Vale Avenue
Tunbridge Wells
TN11DJ

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 8am - 5:30pm
Friday 9am - 5:30pm

Telephone

+441892577706

Alerts

Be the first to know and let us send you an email when Medthority posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share